# A Follow-up Survey to Compare Stable Dosing (SERETIDE) With SYMBICORT, SMART, Maintenance and Reliever Therapy in One Inhaler in Moderate and Severe Asthmatics.

> **NCT00858286** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 56 (actual)

## Conditions studied

- Asthma

## Interventions

- **OTHER:** Spirometry, PEF measurements and diary cards to evaluate control of Asthma

## Key facts

- **NCT ID:** NCT00858286
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2014-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00858286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00858286, "A Follow-up Survey to Compare Stable Dosing (SERETIDE) With SYMBICORT, SMART, Maintenance and Reliever Therapy in One Inhaler in Moderate and Severe Asthmatics.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00858286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*